These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30061703)

  • 21. High throughput gene sequencing reveals altered landscape in DNA damage responses and chromatin remodeling in sporadic pancreatic neuroendocrine tumors.
    Ji S; Yang W; Liu J; Zhao J; Chen L; Ni Q; Long J; Yu X
    Pancreatology; 2018 Apr; 18(3):318-327. PubMed ID: 29395620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.
    Ocsenas O; Reimand J
    PLoS Comput Biol; 2022 Aug; 18(8):e1010393. PubMed ID: 35947558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes.
    Liu H; Liu X; Zhang S; Lv J; Li S; Shang S; Jia S; Wei Y; Wang F; Su J; Wu Q; Zhang Y
    Nucleic Acids Res; 2016 Jan; 44(1):75-94. PubMed ID: 26635396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation Signatures Depend on Epigenomic Contexts.
    Coleman N; De S
    Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
    Tan H; Zhou X
    Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body-hypomethylated human genes harbor extensive intragenic transcriptional activity and are prone to cancer-associated dysregulation.
    Mendizabal I; Zeng J; Keller TE; Yi SV
    Nucleic Acids Res; 2017 May; 45(8):4390-4400. PubMed ID: 28115635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pan-organ transcriptome variation across 21 cancer types.
    Hu W; Yang Y; Li X; Zheng S
    Oncotarget; 2017 Jan; 8(4):6809-6818. PubMed ID: 28036280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
    Klauschen F
    Pathologe; 2014 Nov; 35 Suppl 2():277-80. PubMed ID: 25394977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics.
    Gatto F; Schulze A; Nielsen J
    Cell Rep; 2016 Jul; 16(3):878-95. PubMed ID: 27396332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.
    Zhou N; Hu Z; Wu C; Bao J
    Biosystems; 2018 Apr; 166():37-42. PubMed ID: 29278730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
    Rhee JK; Jung YC; Kim KR; Yoo J; Kim J; Lee YJ; Ko YH; Lee HH; Cho BC; Kim TM
    Cancer Immunol Res; 2018 Jan; 6(1):87-97. PubMed ID: 29141981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex.
    Federico A; Rienzo M; Abbondanza C; Costa V; Ciccodicola A; Casamassimi A
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of normal adjacent to tumor transcriptomes.
    Aran D; Camarda R; Odegaard J; Paik H; Oskotsky B; Krings G; Goga A; Sirota M; Butte AJ
    Nat Commun; 2017 Oct; 8(1):1077. PubMed ID: 29057876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.
    Yang Z; Jones A; Widschwendter M; Teschendorff AE
    Genome Biol; 2015 Jul; 16(1):140. PubMed ID: 26169266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
    Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ
    Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
    Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
    Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico saturation mutagenesis of cancer genes.
    Muiños F; Martínez-Jiménez F; Pich O; Gonzalez-Perez A; Lopez-Bigas N
    Nature; 2021 Aug; 596(7872):428-432. PubMed ID: 34321661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers.
    Heim D; Budczies J; Stenzinger A; Treue D; Hufnagl P; Denkert C; Dietel M; Klauschen F
    Int J Cancer; 2014 Nov; 135(10):2362-9. PubMed ID: 24706491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.